EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures

Jun-Seok Lee, Geon-U Kim, Ho-Young Jung, Young-Hoon Kim iD, Sang-Il Kim, Sangjun Park iD, Young-Yul Kim iD, Hyung-Youl Park iD

Journal of Clinical Medicine · 19.03.2026 · 15 (6) · 2349

DOI: 10.3390/jcm15062349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.03.2026. Verfasst von Jun-Seok Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Kore…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Catholic Medical Center Research Foundation, the National Research Foundation of Korea (NRF), Catholic Medical Center Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Osteoporotic vertebral fractures (OVFs) are frequently associated with progressive kyphotic deformity and vertebral height loss, adversely affecting spinal alignment and function. Although romosozumab and teriparatide are established anabolic therapies, comparative data on their longitudinal radiologic effects after OVFs remain limited. This study compared radiologic and clinical outcomes between these agents in patients with OVFs.

Methods

Sixty-two patients with single-level OVFs were included: 34 patients in the romosozumab group and 28 patients in the teriparatide group, analyzed in a retrospective, observational comparative study. All patients received anabolic therapy for 6 months followed by sequential denosumab. Radiologic parameters (Cobb angle, vertebral wedge angle, and anterior and middle vertebral body heights) were evaluated at baseline and at 1, 3, 6, and 12 months. Bone mineral density (BMD) and clinical outcomes were assessed at baseline and 12 months.

Results

Baseline characteristics were comparable between groups. No statistically significant between-group differences were observed in radiologic parameters over 12 months. However, the romosozumab group showed numerically smaller increases in kyphotic angles and less vertebral height loss, particularly beyond 6 months. Lumbar spine BMD increased in both groups, with a greater absolute gain in the romosozumab group. Back pain improved substantially in both groups, while disability improvement was greater in the teriparatide group.

Conclusions

Romosozumab and teriparatide demonstrated comparable radiologic and clinical outcomes in OVFs. Although differences were not statistically significant, romosozumab showed a numerical trend toward better preservation of spinal alignment and vertebral height.

Schlagwörter

Stichwörter der Autor:innen

bone mineral densityosteoporotic vertebral fractureromosozumabspinal alignmentteriparatide

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
  • Department of Orthopedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Orthopedic Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon 34943, Republic of Korea.

ORCID-Profile: Young-Hoon Kim, Sangjun Park, Young-Yul Kim, Hyung-Youl Park

Förderung

  • the Catholic Medical Center Research Foundation
  • the National Research Foundation of Korea (NRF)
  • Catholic Medical Center Research Foundation
  • National Research Foundation of Korea

Zitieren

APA

Lee, J. S., Kim, G. U., Jung, H. Y., Kim, Y. H., Kim, S. I., Park, S., Kim, Y. Y., & Park, H. Y. (2026). Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures. Journal of Clinical Medicine, 15(6), 2349. https://doi.org/10.3390/jcm15062349

Vancouver

Lee JS, Kim GU, Jung HY, Kim YH, Kim SI, Park S, et al. Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures. Journal of Clinical Medicine. 2026;15(6):2349. doi:10.3390/jcm15062349

BibTeX
@article{Lee2026,
  author = {Lee, Jun-Seok and Kim, Geon-U and Jung, Ho-Young and Kim, Young-Hoon and Kim, Sang-Il and Park, Sangjun and Kim, Young-Yul and Park, Hyung-Youl},
  title = {Comparative Radiologic Outcomes of Romosozumab and Teriparatide in Osteoporotic Vertebral Fractures},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {2349},
  doi = {10.3390/jcm15062349}
}
Kostenlos starten →